Most founders talk about solving problems they found in a boardroom. Dr. Thuria Wenbar found hers at 3 a.m. in the emergency department, watching patients wait eight hours for an asthma inhaler. That frustration became Evaro, one of the UK’s fastest-growing embedded healthcare platforms, and the story of how it got there holds lessons every business leader should study.
Wenbar arrived in Britain as a seven-year-old asylum seeker from Iraq in 1999. Her parents, both doctors back home, took whatever work was available. Her father worked nights as a hotel receptionist. Her mother cared for elderly residents on their block in exchange for housing. The family stuffed gift cards into plastic sleeves at £5 per thousand to supplement their income. None of it was glamorous, but all of it mattered. Those early years taught Wenbar something that no MBA program can replicate: resourcefulness without complaint.
The origin story that shapes a company
What makes Wenbar’s trajectory remarkable is not the hardship itself. Plenty of entrepreneurs carry difficult backstories. What sets her apart is how deliberately she converted every challenge into a competitive advantage.
She took six A-levels. She taught herself to code as a child. When she worked up the courage to tell her parents she wanted to become a software engineer, they pushed her firmly toward medicine, honoring a family tradition that stretched back to her grandmother. So she did both. She studied medicine at the University of East Anglia, drawn to its practical, hands-on curriculum, and she kept coding on the side.
That dual fluency in medicine and technology would prove to be the exact combination the healthcare industry desperately needed. For leaders evaluating healthtech investments or partnerships, Wenbar’s background is instructive. The most disruptive founders in regulated industries tend to carry deep domain expertise alongside technical capability. They do not just understand the technology. They understand the patient.
When the problem becomes impossible to ignore
After qualifying, Wenbar chose emergency medicine. Her first overnight shift at James Paget University Hospital in Norfolk threw her straight into the deep end when a patient suffered a heart attack in a hospital lift. She thrived in the intensity. But one pattern kept nagging at her.
A significant portion of the patients filling A&E beds did not actually need emergency care. They had urinary tract infections. They needed migraine medication. They required the morning-after pill. Every one of those conditions felt urgent and debilitating to the individual, but none of them required a hospital visit. The problem was simple: these patients could not get same-day GP appointments, so they flooded emergency departments instead.
Wenbar started developing algorithms that could assess patients before they arrived at A&E, enabling prescription medications to be issued in advance where appropriate. She pitched the concept to the NHS. The response, by her own account, was dismissive. They laughed her out of the room.
Most people would have shelved the idea. Wenbar chose a different path.
Building embedded healthcare from scratch
In 2018, Wenbar and her husband Dr. Oskar Wenbar, a pharmacist researcher she had met during her first year at university, co-founded Evaro. The embedded healthcare model they envisioned was radical in its simplicity: bring regulated prescription services directly into the digital platforms where people already spend their time, removing the bottleneck of traditional GP access entirely.
The early days looked nothing like a venture-backed startup. Oskar quit his job managing a local pharmacy and signed a six-year lease on a 2,000-square-foot warehouse. They bought shelving secondhand. Wenbar used her medical license to consult with patients. Oskar used his pharmacy license to dispense medications. They funded operations by picking up locum shifts at hospitals on nights and weekends.
Their website launched with just 18 medicines, all targeting the common conditions Wenbar had seen overwhelming A&E departments. The site itself was, in Wenbar’s words, held together with duct tape. She spent late nights in Facebook coding forums, troubleshooting problems she could not solve alone. When one forum member spent more than two hours helping her debug an issue, she hired him as Evaro’s first engineer.
This kind of scrappy, resourceful execution is something that polished pitch decks rarely capture. For investors and board members reading this, it is worth noting: the founders who build with duct tape and secondhand shelving often develop operational instincts that outlast the founders who start with surplus capital.
The moment that changes everything
December 2019 nearly broke the company. Evaro could not make payroll for the end of January. Wenbar responded by working 18 nightshifts in 25 days at hospitals, pouring the locum income directly back into the business. That level of personal sacrifice is unsustainable, and she knew it. The experience forced a strategic reckoning that ultimately made Evaro stronger.
Wenbar and her team slimmed the operation down. They let team members go. They improved their financial literacy. They narrowed their treatment focus to the areas where unit economics worked. The company pushed hard toward profitability, and they achieved it.
Every founder will face a version of this moment. The ones who survive it tend to share a common trait: they treat near-failure as data, not as defeat. Wenbar did not romanticize the struggle. She analyzed it, adjusted course, and built a leaner, more focused business.
Why embedded healthcare is the next infrastructure play
The concept of embedded healthcare follows a pattern that business leaders will recognize from other industries. Embedded finance transformed how people access banking services. Stripe and Plaid made it possible for any platform to offer financial products without becoming a bank. Evaro is applying the same logic to healthcare.
Through its platform, consumer brands can integrate regulated prescription services directly into their existing customer experiences. The period-tracking app Clue partnered with Evaro in 2025 to offer NHS-funded contraception through its interface. The sexual wellness retailer Lovehoney embedded prescription treatments for conditions relevant to its customer base. In each case, Evaro handles the clinical infrastructure, regulatory compliance, prescribing, dispensing, and aftercare. The partner brand provides the customer relationship and distribution channel.
For the brands, this creates a meaningful new revenue stream with minimal implementation effort. Evaro reports that integrations can go live in as little as two weeks. For patients, the model removes friction. Instead of waiting weeks for a GP appointment, they access care through a platform they already trust, in a process that feels as intuitive as online banking.
The scale of the opportunity is significant. Over 20 million people in the UK experienced waits of a month or longer for a GP appointment in 2024, a figure that has climbed 60 percent in seven years. Evaro positions its embedded healthcare infrastructure as a pressure valve, addressing minor conditions that do not require face-to-face consultations while freeing up GP capacity for patients who need it most.
The regulatory moat that protects the model
What separates Evaro from the wave of healthtech startups that have struggled with compliance is the depth of its regulatory foundation. The company holds licenses from the Care Quality Commission, the General Pharmaceutical Council, and the NHS. It maintains seven active regulatory approvals and has NHS integration that enables GP record access for safer prescribing.
Wenbar and her team spent seven years building this infrastructure before pushing aggressively for scale. That patience is rare in startup culture, but it created a competitive advantage that is extraordinarily difficult to replicate. Any consumer brand wanting to offer healthcare services faces a daunting regulatory landscape. Evaro has already navigated it, and that navigation constitutes a genuine moat.
In January 2026, the company closed a $25 million Series A funding round led by AlbionVC, with participation from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI. The round validates not just the technology but the embedded healthcare model itself. Evaro now serves over 2 million patients, supports more than 80 conditions, and operates from an 18,000-square-foot pharmacy fulfillment center with a team of 240 staff, including 30 engineers.
Lessons from a founder who codes, treats patients, and leads
Wenbar still picks up A&E shifts every few months to stay connected to frontline medicine. That decision is not sentimentality. It is strategic. The best product decisions at Evaro continue to flow from direct observation of how patients interact with the healthcare system. Leaders who lose touch with the front line of their industry lose the insight that drives meaningful innovation.
Her advice to fellow entrepreneurs is characteristically direct. Understand why you are doing it, she says, because the journey will test you in ways you cannot anticipate. If the underlying motivation is not deep enough, the difficulty will eventually win.
Wenbar’s company also earned a place on the 2026 Sunday Times 100 Tech ranking, with revenues of £12.1 million growing at 110 percent annually over the past three years. The business has created 164 jobs. Those are not just metrics. They are evidence that embedded healthcare has moved from concept to commercial reality.
What executives should take from this story
The Evaro story is not just about healthcare, and it is not just about technology. It is about what happens when a founder carries both the clinical expertise to understand a broken system and the technical skill to rebuild it from the ground up.
For executives evaluating the embedded healthcare space, three takeaways stand out. First, the companies that invest in regulatory infrastructure early gain advantages that compound over time. Second, the embedded model works because it meets customers where they already are, a principle that applies far beyond healthcare. Third, founders who maintain proximity to their end users build better products, period.
Wenbar once summarized her personal philosophy with a phrase she carries from her upbringing: “I have two hands. He has two hands. I have two eyes. He has two eyes. Anything he can do, I can do.” That conviction, forged in the lived experience of rebuilding a life from scratch, is the same energy that now powers a platform reshaping how millions of people access care.
The embedded healthcare revolution is just getting started. And the doctor who was laughed out of the room is now leading it.
